Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy
-
* Corresponding author: Duncan Wyncoll duncan.wyncoll@gstt.nhs.uk
Critical Care 2008, 12:R163 doi:10.1186/cc7163
Accesses
- Last 30 days: 41 accesses
- Last year: 434 accesses
- All time: 3070 accesses
Cited by
BioMed Central: 2 citations
|
Year in review 2008: Critical Care - nephrology Zaccaria Ricci, Claudio Ronco Critical Care 2009, 13:227 (21 October 2009) |
|
Anne CJM de Pont, Marcus J Schultz Critical Care 2009, 13:113 (2 February 2009) |